APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $13,662,814 | +36.3% | 149,976 | -1.3% | 0.07% | +25.9% |
Q1 2023 | $10,025,590 | +152.2% | 151,995 | +97.7% | 0.05% | +134.8% |
Q4 2022 | $3,975,517 | +995.2% | 76,881 | +1346.8% | 0.02% | +1050.0% |
Q3 2022 | $363,000 | -18.4% | 5,314 | -43.5% | 0.00% | 0.0% |
Q4 2021 | $445,000 | -82.6% | 9,406 | -87.9% | 0.00% | -84.6% |
Q3 2021 | $2,554,000 | +119.4% | 77,495 | +320.7% | 0.01% | +116.7% |
Q2 2021 | $1,164,000 | – | 18,421 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |